Facebook Twitter LinkedIn Google Plus RSS

Celgene stockholders approve two-for-one stock split

By ,

Summit-based Celgene Corporation, a global biopharmaceutical company, announced Thursday that its stockholders approved a two-for-one stock split that will increase the total number of shares of common stock from about 399 million to about 798 million.

Stockholders of record as of June 18 will be entitled to receive one additional share of common stock for each share they hold. The shares are expected to be distributed June 25.

ALSO ON NJBIZ:

Morristown property sold in reported $52 million deal

Be careful: For legal reasons, ACA-prompted wellness programs must be structured carefully

Top 10 rankings of New Jersey's best places for homeownership

You May Have Missed...

Emily Bader

Emily Bader

Emily Bader is the copy and web editor at NJBIZ. She is a Brielle, N.J. native and a Rutgers University alum. You can contact her at emilyb@njbiz.com or @emilybader on Twitter.

Leave a Comment

test

Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy

Comments

close
Subscribe to Our Newsletters!
Click Here to Subscribe for Free Now!